Publications
Download list of publications, May 13th, 2013 (PDF file)Cover Art Gallery
2013
2013-6: Asymmetric Catalysis with Inert
Chiral-At-Metal Iridium Complex
L.-A. Chen, W. Xu, B. Huang, J. Ma, L. Wang, J. Xi, K.
Harms, L. Gong, E. Meggers, J. Am. Chem. Soc. 2013, DOI:
10.1021/ja403777k
abstract: The development of a chiral-at-metal iridium(III) complex for the highly efficient catalytic asymmetric transfer hydrogenation of beta, beta’-disubstituted nitroalkenes is reported. Catalysis by this inert, rigid metal complex does not involve any direct metal coordination but operates exclusively through cooperative, weak interactions with functional groups properly arranged in the ligand sphere of the iridium complex. Although the iridium complex only relies on the formation of three hydrogen bonds, it exceeds the performance of most organocatalysts with respect to enantiomeric excess (up to 99% ee) and catalyst loading (down to 0.1 mol%). This work hints towards an advantage of structurally complicated, rigid scaffolds for non-covalent catalysis which especially relies on conformationally constrained, cooperative interactions between catalyst and substrates.
2013-5: Method for the Preparation of Non-Racemic
Bis-Cyclometalated Iridium(III) Complexes
M. Helms, Z. Lin, L. Gong, K. Harms, E. Meggers, Eur.
J. Inorg. Chem. 2013, accepted for publication
abstract: A straightforward method for the synthesis of virtually enantiomerically pure ruthenium(II) polypyridyl complexes [Ru(pp)(pp’)(pp’’)](PF6)2, pp = bidentate polypyridyl has been developed. The synthesis draws from the readily available racemic starting material cis-[Ru(pp)(pp’)Cl2] and the natural amino acids L- or D-proline and relies on a dynamic asymmetric transformation under thermodynamic control.
2013-4: Rhenium Complexes with
Visible-Light-Induced Anticancer Activity
A. Kastl, S. Dieckmann, K. Wähler, T. Völker, L. Kastl,
A. L. Merkel, a. Vultur, B. Shannan, K. Harms, M. Ocker, W. Parak, M.
Herlyn, E. Meggers, ChemMedChem 2013, published online
abstract: This publication introduces a new class of potent visible-light-triggered anticancer organometallics based on rhenium(I) indolato complexes. This is unexpected since related rhenium(I) tricarbonyl polypyridyl complexes are well established nontoxic luminescence probles routinely applied for biological imaging.
2013-3: Chiral-Auxiliary-Mediated Asymmetric
Synthesis of Ruthenium Polypyridyl Complexes
L. Gong, M. Wenzel, E. Meggers, Acc. Chem. Res. 2013,
accepted for publications
abstract: A few years ago our laboratory embarked on a project exploring new and general synthetic strategies for the asymmetric synthesis of inert octahedral transition metal complexes by initially using the example of thermally inert ruthenium polypyridyl complexes. As a result of these efforts, we developed a family of chiral bidentate ligands, including salicyloxazolines, (mercaptophenyl)oxazolines, sulfinylphenols, N-acetylsulfinamides, a phosphinohydroxybinaphthyl, and even the amino acid proline to serve as chiral auxiliaries for asymmetric coordination chemistry. The applications of these auxiliaries for the asymmetric synthesis of non-racemic ruthenium(II) polypyridyl complexes is discussed.
2013-2: Thioether-Based Anchimeric
Assistance for Asymmetric Coordination Chemistry with Ruthenium(II) and
Osium(II)
L.-A. Chen, X. Ding, L. Gong, E. Meggers, Dalton Trans.
2013, 42, 5623-5626
abstract: (R)-4-(Alkylthiomethyl)-5,5-dimethyl-2-(2’-hydroxyphenyl)-2-oxazolines are demonstrated to be highly suitable chiral auxiliaries for the two-step conversion of the half-sandwich complex [Ru(C6H6)(bpy)Cl]Cl, bpy = 2,2’-bipyridine, into delta-configured ruthenium polypyridyl complexes. The tailored thioether substituent at the oxazoline ring is essential for this conversion and not only promotes the removal of the benzene moiety but also controls the absolute metal-centered configuration. Applied to osmium, this strategy resulted in the first highly asymmetric synthesis of delta-[Os(bpy)3](PF6)2.
2013-1: Metal Complex Catalysis in Biological Systems
P. K. Sasmal, C. N. Streu, E. Meggers, Chem. Commun.
2013, 49, 1581-1587
abstract: This Feature article discusses synthetic metal complexes that are capable of catalyzing chemical transformations in living organisms. Over the last few years, significant progress has been made towards the application of non-biological reactions in living systems, ranging from the organoruthenium-catalyzed cleavage of allylcarbamates and a gold-catalyzed intramolecular hydroarylation to palladium-catalyzed Suzuki-Miyaura and Sonogashira cross-couplings within the cytoplasm or on the surface of living cells. The design of bioorthogonal catalyst/substrate pairs, which can passively diffuse into cells, combines the advantages of small molecules with catalysis and promises to provide exciting new tools for future chemical biology studies.
2012
2012-14: Proline as Chiral Auxiliary for the
Economical Asymmetric Synthesis of Ruthenium(II) Polypyridyl
Complexes
C. Fu, M. Wenzel, E. Treutlein, K. Harms, E. Meggers,
Inorg. Chem. 2012, 51, 10004-10011
abstract: A straightforward method for the synthesis of virtually enantiomerically pure ruthenium(II) polypyridyl complexes [Ru(pp)(pp’)(pp’’)](PF6)2, pp = bidentate polypyridyl has been developed. The synthesis draws from the readily available racemic starting material cis-[Ru(pp)(pp’)Cl2] and the natural amino acids L- or D-proline and relies on a dynamic asymmetric transformation under thermodynamic control.
L.-A. Chen, J. Ma, M. A. Celik, H.-L. Yu, Z. Cao, G.
Frenking, L. Gong, E. Meggers, Chem. Asian J. 2012, 7, 2523-2526
abstract: We here report a surprising sulfur-effect for the chirality transfer from carbon to metal, most likely relying on the active participation of a transiently coordinating thioether substituent, causing a reversal of the stereochemical outcome compared to the commonly applied passive steric control of chiral substituents.
N. L. Kilah, E. Meggers, Aust. J. Chem. 2012, 65,
1325-1332
abstract: Sixty years ago, the Australian chemist Francis P. Dwyer pioneered the use of ruthenium polypyridyl complexes as biologically active compounds. This review commemorates the sixtieth anniversary of Dwyer and co-workers’ landmark 1952 publication, summarises their broader achievements in biological inorganic chemistry, and discusses the contribution of this work to the development of modern biological and medicinal inorganic chemistry.
2012-11: GSK3-beta Inhibition Blocks Melanoma Cell/Host Interaction by Downregulating N-Cadherin Expression and Decreasing FAK Phosphorylation
J. K. John, K. H. T. Paraiso, V. W. Rebecca, L. P.
Cantini, E. V. Abel, N. Pagano, E. Meggers, R. Mathew, C. Krepler, V.
Izumi, B. Fang, J. M. Koomen, J. L. Messina, M. Herlyn, K. S. M.
Smalley, J. Investigative Dermatology 2012, published online
abstract: This study addresses the role of glycogen synthase-3 kinase (GSK3) signaling in the adhesive and migratory behavior of melanoma cells using the organometallic GSK3 inhibitor NP309 as a tool.
S. Blanck, Y. Geisselbrecht, K. Kräling, S. Middel, T. Mietke, K. Harms, L.-O. Essen, E. Meggers, Dalton Transactions 2012, 41, 9337-9348
abstract: The regioselective cyclometalation of 4-(pyridin-2-yl)phthalimide was exploited for the economical design of organometallic protein kinase inhibitors. The versatility of this new ligand was demonstrated with the synthesis of ruthenium(II) half-sandwich as well as octahedral ruthenium(II) and iridium(III) complexes. A cocrystal structure of one metallo-phthalimide with the protein kinase Pim1 confirmed an ATP-competitive binding with the intended hydrogen bonding between the phthalimide moiety and the hinge region of the ATP-binding site.
2012-9: PIM1 Kinase as a Target for Cancer Therapy
A. L. Merkel, E. Meggers, M. Ocker, Expert Opin. Investig. Drugs 2012, 21, 425-436
abstract: A review. Inhibition of protein kinases has become a standard of modern clinical oncology. PIM1 is overexpressed in human cancer diseases and has been associated with metastasis and overall treatment response. We here review the biologic functions of PIM1, its role in human cancer diseases, present the current state of the art of PIM1 inhibitor design and highlight the development of the unusual class of highly selective and potent organometallic PIM1 inhibitors which great promise as novel anticancer agents.
2012-8: Hydrolytically Stable Octahedral Silicon
Complexes as Bioactive Scaffolds: Application to the Design of DNA
Intercalators
Y. Xiang, C. Fu, T. Breiding, P. K. Sasmal, H. Liu, Q.
Shen, K. Harms, L. Zhang, E. Meggers, Chem. Commun. 2012, 48,
7131-7133
abstract: We here introduce octahedral silicon serving as a structural center for the design of hydrolytically stable bioactive complexes as demonstrated with the generation of silicon-based high affinity DNA binders. This proof-of-principle study suggests that octahedral silicon complexes are falsely neglected, promising structural templates for widespread applications in chemical biology and medicinal chemistry.
2012-7: Cyclometalated Phenylquinoline Rhodium
Complexes as Protein Kinase Inhibitors
S. Mollin, S. Blanck, K. Harms, E. Meggers, Inorg.
Chim. Acta 2012, published online
abstract: A new metal-containing scaffold for the generation of rhodium(III)-based protein kinase inhibitors is introduced in which the pharmacophore ligand 4-phenylpyrrolo[3,4-c]quinoline-1,3(2H)-dione is designed to form two hydrogen bonds with the hinge region of the ATP-binding site. The phenylquinoline ligand binds to rhodium(III) in a cyclometalated fashion by coordinating to the quinoline nitrogen and forming a covalent bond to a carbon atom of the phenyl substituent.
2012-6: Light-Triggered Ruthenium-Catalyzed
Allylcarbamate Cleavage in Biological Environments
P. K. Sasmal, S. Carregal-Romero, W. J. Parak, E.
Meggers, Organometallics 2012, 31, 5968-5970
abstract: The sandwich complex [Cp*Ru(pyrene)]PF6 serves as a photoactivatable catalyst for the conversion of N-allylcarbamates into their amines in the presence of thiophenol under biorelevant conditions (water, air, plus aliphatic thiols) and even in mammalian cells.
M. Wenzel, E. Meggers, Eur. J. Inorg. Chem. 2012,
3168-3175
abstract: Mercaptophenyloxazolines were used as chiral auxiliaries for the asymmetric synthesis of polypyridyl ruthenium complexes. Key step was the conversion of a coordinated thiolate into a labilized thioether upon methylation with Meerwein salt, followed by a thermal substitution with an achiral ligand under retention of configuration.
2012-4: Catalytic Azide Reduction in Biological
Environments
P. K. Sasmal, S. Carregal-Romero, C. N. Streu, Z. Lin,
K. Namikawa, S. L. Elliott, R. W. Köster, W. J. Parak, E. Meggers,
ChemBioChem 2012, 13, 1116-1120
abstract: In the quest for the identification of catalytic transformations to be used in Chemical Biology and Medicinal Chemistry, we identified iron(III) meso-tetraarylporphines as efficients catalysts for the reduction of aromatic azides to their amines. The reaction uses thiols as the reducing agent and tolerates water, air, and other biological components.
2012-3: About the Art of Filling Protein Pockets Efficiently with Octahedral Metal Complexes
S. Blanck, J. Maksimoska, J. Baumeister, K. Harms, R.
Marmorstein, E. Meggers, Angew. Chem. Int. Ed. 2012, 51,
5244-5246
abstract: A very important aspect regarding the design of enzyme inhibitors based on octahedral metal complex scaffolds is the position of the metal within the active site. In this work, two different octahedral scaffolds are compared regarding their binding to the same protein pocket.
S. Dieckmann, R. Riedel, K. Harms, E. Meggers, Eur. J.
Inorg. Chem. 2012, 813-821
abstract: Whereas previous work from our laboratory was predominantly based on ruthenium(II), this study evaluates the suitability of rhodium in the oxidation state III to serve as a structural center for designing inert metal-based enzyme inhibitors. Based on our established staurosporine-inspired metallo-pyridocarbazole scaffold, strategies for the convenient synthesis of rhodium(III)-pyridocarbazole complexes were developed and applied to the synthesis of protein kinase inhibitors.
Link to articleA. Kastl, A. Wilbuer, A. L. Merkel, L. Feng, P. Di
Fazio, M. Ocker, E. Meggers, Chem. Commun. 2012, 48, 1863-1865
abstract: A metal complex is identified in which the metal fulfills two independent functions: as a structural scaffold for the specific molecular recognition of protein kinases resulting in antiangiogenic properties, together with a visible-light-induced photoreactivity triggering apopotosis in cancer cells.
Link to article2011
Z. Lin, M. A. Celik, C. Fu, K. Harms, G. Frenking, E.
Meggers, Chem. Eur. J. 2011, 17, 12602-12605
abstract: We have discovered N-acetyl-tert-butanesulfinamide as a novel chiral bidentate ligand and applied it to the asymmetric synthesis of octahedral ruthenium polypyridyl complexes. This auxiliary is highly appealing due to its convenient accessibility from Ellman’s sulfinamide in a single step. To the best of our knowledge, the coordination of N-acetyl-tert-sulfinamide through the formation of a chelating N-sulfinylcarboximidate has not been reported before.
Link to article
A. T. Johnson, M. K. Schlegel, E. Meggers, L.-O. Essen,
O. Wiest, J. Org. Chem. 2011, 76, 7964-7974
abstract: A herein presented new crystal structure of a GNA duplex at 1.8 Å resolution from self-complementary 3’-CTCBrUAGAG-2’ GNA oligonucleotides reveals an N-type conformation with alternating gauche-anti torsions along its (O3'-C3'-C2'-O2') backbone. To elucidate the conformational state of dsGNA in solution, molecular dynamic simulations over a period of 20 ns were performed with the repertoire of now available structural information from the three crystal structures. Interestingly, dsGNA exists in solution as in conformational states intermediate between experimentally observed backbone conformations: simulated dsGNA shows the all-gauche conformation of the M-type GNA with the higher helical twist observed in N-type GNA structures.
C. Streu, L. Feng, P. J. Carroll, J. Maksimoska, R.
Marmorstein, E. Meggers, Inorg. Chim. Acta
2011, 377, 34-41
abstract: Reported is the design, synthesis, and evaluation of protein kinase inhibition properties of pyridocarbazole half-sandwich complexes containing P-donor ligands. The nature of the monodentate P-donor ligand has a strong effect on protein kinase binding properties, most likely due to a direct interaction with the glycine-rich loop in the ATP-binding site.
S. Blanck, T. Cruchter, A. Vultur, R. Riedel, K. Harms,
M. Herlyn, E. Meggers, Organometallics 2011, 30,
4598-4606
abstract: A new metal-containing scaffold for the design of protein kinase inhibitors is introduced. Key feature is a 3-(2-pyridyl)-1,8-naphthalimide “pharmacophore chelate ligand” which is designed to form two hydrogen bonds with the hinge region of the ATP-binding site and is at the same time capable of serving as a stable bidentate ligand through C-H-activation at the 4-position of the electron-deficient naphthalene moiety. This C-H-activation leads to a reduced demand for coordinating heteroatoms and thus sets the basis for a very efficient three-step synthesis starting from 1,8-naphthalic anhydride. The versatility of this ligand is demonstrated with the discovery of a ruthenium complex that functions as a nanomolar inhibitor for myosin light-chain kinase.
J. Spencer, J. Amin, P. Coxhead, J. McGeehan, C. J.
Richards, G. J. Tizzard, S. J. Cole, J. P. Bingham, J. A. Hartley, L.
Feng, E. Meggers, M. Guille, Organometallics 2011, 33, 3177-3181
abstract: Bulky oxindole-complexes have been synthesized and tested for anticancer activity and were found to be inactive against a range of kinase targets compared with their simpler, less bulky ferrocene analog. Space-filling models emphasize the dramatic difference in the metal complex bulk around the common oxindole unit, which leads us to conclude that the bulky environment may disfavor binding in the ATP pocket of kinases, including that of PAK1.
E. Meggers, Eur. J. Inorg. Chem. 2011,
2911-2926
abstract: This microreview provides an overview of the asymmetric coordination chemistry of octahedral metal complexes within the historical context, including asymmetric coordination chemistry evolved by Nature, the predetermination of metal-centered chirality with tailored chiral ligands, chiral-anion-mediated and chiral-auxiliary-mediated asymmetric synthesis, and a recent example of the catalytic asymmetric synthesis of an octahedral coordination complex.
L. Feng, Y. Geisselbrecht, S. Blanck, A. Wilbuer, G. E.
Atilla-Gokcumen, P. Filippakopoulos, K. Kräling, M. A. Celik, K. Harms,
J. Maksimoska, R. Marmorstein, G. Frenking, S. Knapp, L.-O. Essen, E.
Meggers, J. Am. Chem. Soc. 2011, 133,
5976-5986
abstract: The generation of synthetic compounds with exclusive target specificity is an extraordinary challenge of molecular recognition and demands novel design strategies, in particular for large and homologous protein families such as protein kinases with more than 500 members. Simple organic molecules often do not reach the necessary sophistication to fulfill this task. Here, we present six carefully tailored, stable metal-containing compounds in which unique and defined molecular geometries with natural-product-like structural complexity are constructed around octahedral ruthenium(II) or iridium(III) metal centers. Each of the six reported metal compounds displays high selectivity for an individual protein kinase, namely GSK3alpha, PAK1, PIM1, DAPK1, MLCK, and FLT4.
L. Gong, C. Müller, M. A. Celik, G. Frenking, E.
Meggers, New J. Chem. 2011, 35, 788-793.
abstract: In this study, the bidentate ligand (R)-2-diphenylphosphino-2'-hydroxy-1,1'-binaphthyl (HO-MOP) was investigated as a chiral auxiliary for the asymmetric synthesis of ruthenium polypyridyl complexes. It was found that (R)-HO-MOP serves as an effective chiral auxiliary starting from different precursor complexes, most notably using the commercially available half-sandwich complex [Ru(C6H6)Cl2]2.
Z. Lin, L. Gong, M. A. Celik, K. Harms, G. Frenking, E.
Meggers, Chem. Asian J. 2011, 6, 474-481.
abstract: Dynamic asymmetric transformation at an octahedral ruthenium center: Chiral (R)-2-(isopropylsulfinyl)phenol (R = H) and preferably a more electron rich methoxy derivative (R = OMe) serve as auxiliaries for the asymmetric synthesis of chiral ruthenium polypyridyl complexes starting from racemic cis-[Ru(pp)2Cl2] (pp = 2,2'-bipyridine or 1,10-phenanthroline ligands).
E. Meggers, Angew. Chem. Int. Ed. 2011, 50,
2442-2448.
abstract: The enormous challenge of specific molecular recognition of single biomacromolecular targets within complex biological systems demands novel and creative design strategies. This short review discusses some conventional and unusual approaches for the design of target-selective enzyme inhibitors with a focus on the employed underlying chemical scaffolds.
G. E. Atilla-Gokcumen, L. Di Costanzo, E. Meggers, J.
Biol. Inorg. Chem. 2011, 16, 45-50.
abstract: The 3.15 Å resolution crystal structure of the (R)-enantiomer of the highly bioactive and antiproliferative half-sandwich ruthenium complex DW12 bound to the ATP-binding site of glycogen synthase kinase 3beta (GSK-3b) is reported and compared with the GSK-3b-binding of staurosporine and other organic inhibitors. The structure reveals a close packing of the organometallic inhibitor in the ATP binding site of GSK-3b via an induced fit mechanism. The molecular structure of (R)-DW12 with the CO-ligand oriented perpendicular to the pyridocarbazole heterocycle allows the complex to stretch the whole distance sandwiched between the faces of the N- and C-terminal lobes and to interact tightly with the flexible glycine-rich loop which is uncommon for the interaction of GSK-3b with organic inhibitors.
Link to interactive 3D complement in proteopedia.
2010
L. Gong, Z. Lin, K. Harms, E. Meggers, Angew. Chem.
Int. Ed. 2010, 49, 7955-7957.
abstract: Catalytic asymmetric coordination chemistry made possible by chirality transfer from an organic ligand with sulfur-centered chirality to a chiral-at-metal octahedral ruthenium complex. (S)-2-(isopropylsulfinyl)phenol and a more electron rich methoxy derivative are capable of inducing and even catalyzing a chirality-generating trans-cis isomerization of two 2,2'-bipyridine ligands in an octahedral coordination sphere of a ruthenium complex. Link to article.
To be featured on cover: Link to cover image.
Featured in:
Nature Chemistry (DOI:10.1038/nchem.836
)
Highlighted in ChemCatChem: Link to Early View.
S. P. Mulcahy, E. Meggers, Top. Organomet. Chem. 2010,
32, 141-153.
abstract (review): Substitutionally inert metal-containing compounds provide new opportunities as structurally diverse and unique scaffolds for the design of protein binders. This review cites progress in this area by highlighting the use of metal complexes, including truly organometallic compounds, as inhibitors for enzymes of biological interest, such as esterases, proteases, and protein kinases.
download article · 2290K PDF2010-7: Discovery of a Strongly Apoptotic Ruthenium Complex through Combinatorial Coordination Chemistry
S. P. Mulcahy, K. Gründler, C. Frias, L. Wagner, A.
Prokop, E. Meggers, Acc. Dalton Trans. 2010, 39,
8177-8182.
abstract: A simple octahedral ruthenium complex with striking apoptotic properties was identified through combinatorial chemistry, subsequent screening, and followed by a brief structure-activity relationship. Link to article.
L. Gong, S. P. Mulcahy, D. Devarajan, K. Harms, G.
Frenking, E. Meggers, Inorg. Chem. 2010, 49, 7692-7699.
abstract: We recently introduced chiral salicyloxazolines as coordinating bidentate chiral ligands which provide excellent control over the metal-centered configuration in the course of ligand substitution reactions and can be removed afterwards in an acid-induced fashion under complete retention of configuration (J. Am. Chem. Soc. 2009, 131, 9602-9603). Herein we report our detailed investigation of this reaction sequence, reveal the scope of this method, and provide a guide to optimal standard reaction conditions. Link to article.
X. He, L. Gogn, K. Kräling, K. Gründler, C. Frias, R.
D. Webster, E. Meggers, A. Prokop, H. Xia, Chem. Bio. Chem. 2010, 11,
1607-1613.
abstract: The highly apoptotic properties of a structurally unusual organometallic osmacycle is reported. Despite its chemical stability, the complex strongly induces apoptosis in Burkett-like lymphoma cells and we demonstrate that this occurs through the intrinsic mitochondrial pathway of programmed cell death. The presented results indicated that previously not considered organometallics provide untapped opportunities to be exploited for the discovery and development of future drug candidates. Link to article.
E. Meggers and L. Zhang, Acc. Chem. Res. 2010, 43,
1092-1102.
abstract: The nucleosides of glycol nucleic acid (GNA)—with the backbone comprising just the three carbons and one stereocenter of propylene glycol (1,2-propanediol)—probably constitute the simplest possible building blocks for a chemically stable nucleic acid that contains phosphodiester bonds. However, it was not until 2005 that the astonishing duplex formation properties of GNA homoduplexes were discovered in our laboratory. This account article summarizes and discusses the surprising duplex formation properties of GNA. Link to article.
2010-3: Iridium Complex with Antiangiogenic Properties
A. Wilbuer, D. H. Vlecken, D. J. Schmitz, K. Kräling,
K. Harms, C. P. Bagowski, E. Meggers,
Angew. Chem. Int. Ed. 2010, 49, 3839-3842.
abstract: The discovery of a bioactive octahedral iridium(III) complex, synthesized through oxidative addition as the key synthetic step, is presented. The organometallic compound functions as a nanomolar and selective inhibitor of the protein kinase Flt4 (Fms-related tyrosine kinase 4), also known as VEGFR3 (vascular endothelial growth factor receptor 3). Flt4 is involved in angiogenesis and lymphangiogenesis and it is demonstrated that this nontoxic organoiridium compound can interfere with the development of blood vessels in vivo in two different zebrafish angiogenesis models. Link to article.
Featured in highlight article from C. Kunick and I. Ott: Angew. Chem. Int. Ed. 2010, 49, 5226-5227.
M. K. Schlegel, L.-O. Essen, E. Meggers, Chem.
Commun. 2010, 46, 1094-1096.
abstract: Double helix variations of glycol nucleic acids (GNA) are revealed by the atomic resolution crystal structure of a 6mer GNA duplex containing solely Watson–Crick type hydrogen bonded base pairs. Link to article.
2010-1: Chiral Auxiliaries as Emerging Tools for the Asymmetric Synthesis of Octahedral Metal Complexes
E. Meggers, Chem. Eur. J. 2010, 16,
752-758.
abstract (minireview): New methods for the stereocontrolled synthesis of octahedral metal complexes are needed in order to fully exploit the stereochemical richness of the octahedron in the fields of catalysis, materials sciences, and life sciences. Whereas a large body of work exists regarding the diastereoselective coordination chemistry with chiral ligands, such efforts are restricted to certain carefully designed chiral ligands which remain in the coordination sphere. This short review summarizes reported examples of chiral auxiliaries applied to the asymmetric synthesis of octahedral metal complexes. Link to article.
2009
From Imide to Lactam Metallo-pyridocarbazoles: Distinct Scaffolds for the Design of Selective Protein Kinase Inhibitors
N. Pagano, E. Y. Wong, T. Breiding, H. Liu, A. Wilbuer, H. Bregman, Q. Shen, S. L. Diamond, E. Meggers, J. Org. Chem. 2009, 74, 8997-9009.
abstract: Organometallic pyridocarbazole scaffolds are investigated
as protein kinase inhibitors. Whereas our previous designs employed
solely a maleimide pharmacophore we have now extended our
investigations to include the related lactam metallo-pyridocarbazoles.
Lactam lead structures for the inhibition of the protein kinases TrkA
and CLK2 are reported.
A. N. Bullock, S. Russo, A. Amos, N. Pagano, H. Bregman, J. E. Debreczeni, W. H. Lee, F. von Delft, E. Meggers, S. Knapp, PLoS One 2009, 4, e7112.
abstract: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. Here we determined the crystal structure of PIM2 in complex with an organoruthenium complex.
Chiral-Auxiliary-Mediated Asymmetric Synthesis of Tris-Heteroleptic Ruthenium Polypyridyl Complexes
G. Lei, S. P. Mulcahy, K. Harms, E. Meggers, J. Am. Chem. Soc. 2009, 131, 9602-9603.
abstract: A strategy for the asym. synthesis of chiral-at-metal
[Ru(pp)(pp')(pp'')]2+ complexes, where pp, pp', and pp'' are
achiral 2,2'-bipyridines, is introduced. The method employs
isopropyl-2-(2'-hydroxyphenyl)oxazolines as chiral auxiliaries, which
serve in their deprotonated forms as strong bidentate ligands that
provide excellent asymmetric induction in the course of the
coordination chemistry and, importantly, can afterward become
substituted with complete retention of configuration in the presence of
acid.
The Crystal Structure of BRAF in Complex
with an Organoruthenium Inhibitor Reveals a Mechanism for Inhibition of
an Active Form of BRAF Kinase
P. Xie, C. Streu, J. Qin, H. Bregman, N. Pagano, E. Meggers, R. Marmorstein, Biochemistry 2009, 48, 5187-5198.
abstract: Here we report on the identification and subsequent
optimization of a potent BRAF inhibitor, CS292, based on an
organometallic kinase inhibitor scaffold. A cocrystal structure of
CS292 in complex with the BRAF kinase domain reveals that CS292 binds
to the ATP binding pocket of the kinase and is an ATP competitive
inhibitor. The structure of the kinase-inhibitor complex also
demonstrates that CS292 binds to BRAF in an active conformation and
suggests a mechanism for regulation of BRAF by phosphorylation and
BRAFV600E oncogene-induced activation.
Toward the Development of a Potent and
Selective Organoruthenium Mammalian Sterile 20 Kinase
Inhibitor
R. Anand, J. Maksimoska, N. Pagano, E. Y. Wong, P. A.
Gimotty, A. Phyllis, S. L. Diamond, E. Meggers, R. Marmorstein, J. Med.
Chem. 2009, 52, 1602-1611.
abstract: Mammalian sterile 20 (MST1) kinase, a member of the sterile 20 (Ste-20) family of proteins, is a proapoptotic cytosolic kinase that plays an important role in the cellular response to oxidative stress. In this study, we report on the development of a potent and selective MST1 kinase inhibitor based on a ruthenium half-sandwich scaffold. We show that the enantiopure organoruthenium inhibitor, has an IC50 value of 45 nM for MST1 and a greater than 25-fold inhibitor selectivity over the related Ste-20 kinases. A cocrystal structure of a related compd. with PIM-1 and a homol. model with MST1 reveals the binding mode of this scaffold to MST1 and provides a starting point for the development of improved MST1 kinase inhibitors for possible therapeutic application.
download article · 649K PDFEric Meggers, G. Ekin Atilla-Gokcumen, Katharina
Gründler, Corazon Frias, Aram Prokop, Dalton Trans. 2009,
10882-10888.
abstract: In this study, we investigate the anticancer properties of an inert half-sandwich metal complex scaffold. The ruthenium complexes DW12 and NP309 do not interact with nucleic acids and their anticancer effects are instead due to the inhibition of protein kinases. DW12 and the even more cytotoxic derivative NP309 are thus members of a new class of anticancer metal complexes in which the metal is not directly involved in the mode of action. NP309 efficiently triggers the mitochondrial pathway of apoptosis and shows promising anticancer activities in some drug resistant cell lines.
download article · 376K PDFImproved Phosphoramidite Building Blocks for the
Synthesis of the Simplified Nucleic Acid
GNA
M. K. Schlegel, E. Meggers, J. Org. Chem. 2009, 74, 4615-4618.
abstract: An improved synthesis of glycol nucleic acids is reported using new phosphoramidite building blocks in which the exocyclic amino groups of adenine and guanine are protected as N-dimethylformamidines, whereas the amino group of cytosine is protected via an acetamide. Besides a more rapid synthesis with higher yields, these phosphoramidites allow the use of a quicker deprotection procedure in the subsequent solid-phase synthesis of GNA oligonucleotides.
download article · 171K PDFE. Meggers, Chem. Commun. 2009, 1001-1010.
abstract (review): Unique properties of metal complexes, such as structural diversity, adjustable ligand exchange kinetics, fine-tuned redox activities, and distinct spectroscopic signatures, make them exciting scaffolds not only for binding to nucleic acids but increasingly also to proteins as non-traditional targets. This feature article discusses recent trends in this field.
download article · 1300K PDF
M. K. Schlegel, L. Zhang, N. Pagano, E. Meggers, Org. Biomol. Chem. 2009, 7, 476-482.
abstract: Hydroxypyridone and pyridopurine homo- and hetero-base pairs have been investigated in the context of duplex GNA. The hydroxypyridone homo-base pair and hydroxypyridone-pyridopurine hetero-base pair are particularly well accommodated in the GNA duplex and form copper(II)-dependent base pairs that are more stable compared to a Watson-Crick A:T base pair at the same position by nearly 20 °C and 24 °C, respectively.
download article · 281K PDF
Insight into the High Duplex Stability
of the Simplified Nucleic Acid GNA
M. Schlegel, X. Xie, L. Zhang, E. Meggers,
Angew. Chem. Int. Ed. 2009, 48,
960-963.
abstract: In this communication we shed light on the reasons for the
surprisingly high duplex stability of the simplified nucleic acid GNA.
Thermodynamic measurements demonstrate that the entropic penalty for
GNA duplex formation is significantly smaller compared to DNA, which is
consistent with a strong conformational preorganization of GNA single
strands in addition to especially favorable stacking interactions in
the corresponding GNA duplex, rendering GNA a preorganized zipper with
highly favorable duplex formation properties.
Strategy for the Stereochemical Assignment of
Tris-Hetereoleptic Ru(II) Complexes by NMR Spectroscopy
X. Xie, S. P. Mulcahy, E. Meggers, Inorg.
Chem. 2009, 48, 1053-1061.
abstract: The relative stereochem. of tris-heteroleptic ruthenium
complexes [Ru(pp)(pp')(pp'')](PF6)2, where pp =
1,10-phenanthroline-4-carboxamide, pp' =
5,6-dimethyl-1,10-phenanthroline, and pp'' = 7,8-di-Me
dipyrido[3,2-a:2',3'-c]phenazine, was studied using NMR spectroscopy.
The introduction of an additional chiral center to ligand pp by
coupling it with L-lysine caused removal of the enantiomerism. Thus,
four diastereomers were observed and their relative stereochem.
determined.
2008
Extremely Tight Binding of Ruthenium
Complex to Glycogen Synthase Kinase 3
G. E. Atilla-Gokcumen, N. Pagano, C. Streu, J.
Maksimoska, P. Filippakopoulos, S. Knapp, E. Meggers,
ChemBioChem 2008, 9, 2933.
abstract: An organoruthenium complex with at least low picomolar binding constant for glycogen synthase kinases 3 is reported and its binding to the ATP-binding site analyzed by X-ray crystallography. With a binding constant (Ki) of at most 5 pM, this organometallic compound is by several orders of magnitude more potent than the natural product staurosporine which itself served as an inspiration for the design. The crystal structure of the organoruthenium inhibitor with GSK-3 demonstrates that the metal itself is not involved in any direct interactions with the active site of GSK-3 but soleily serves as a structural center.
download article · 4451K PDFdownload coverpicture · 907K PDF
J. Maksimoska, L. Feng, K. Harms, C. Yi, J. Kissil, R. Marmorstein, E. Meggers, J. Am. Chem. Soc. 2008, 130, 15764-15765.
abstract: A strategy for targeting protein kinases with large ATP-binding sites by using bulky and rigid octahedral ruthenium complexes as structural scaffolds is presented. A highly potent and selective GSK3 and Pim1 half-sandwich complex NP309 was successfully converted into a PAK1 inhibitor by making use of the large octahedral compounds lambda-FL172 and lambda-FL411 in which the cyclopentadienyl moiety of NP309 is replaced by a chloride and sterically demanding diimine ligands. A cocrystal structure of PAK1 with lambda-FL172 reveals how the large coordination sphere of the ruthenium complex matches the size of the active site and serves as a yardstick to discriminate between otherwise closely related binding sites.
download article · 594K PDFDuplex Structure of a Minimal Nucleic Acid
Mark K. Schlegel, Lars-Oliver Essen, Eric Meggers,J. Am. Chem. Soc. 2008, 130, 8158-8159.
abstract: The crystal structure of an 8mer (S)-GNA duplex is presented. As a tool for phasing, the anomalous diffraction of two copper(II) ions within two artificial metallo-base pairs was employed. The antiparallel duplex structure can be described as a right-handed helical ribbon wrapped around the helix. Most intriguingly, neighboring base pairs slide strongly against each other resulting in extensive interstrand base-base hydrophobic interactions along with unusual hydrophobic intrastrand interactions of nucleobases with their backbone.
download article · 990K PDF
Structure-Based Design of an Organoruthenium Phosphatidyl-inositol-3-kinase inhibitor Reveals a Switch Governing Lipid Kinase Potency and Selectivity
Peng Xie, Douglas S. Williams, G. Ekin Atilla-Gokcumen, Leslie Milk, Min Xiao, Keiran S. M. Smalley, Meenhard Herlyn, Eric Meggers, Ronen Marmorstein, ACS Chem. Biol. 2008, 3, 305-316.
abstract: In this study, we report the design of an organoruthenium half-sandwich complex as a selective inhibitor for PI3K over protein kinases. This selectivity is largely due to a single methyl group.
download article · 2000K PDFJasna Maksimoska, Douglas S. Williams, G. Ekin Atilla-Gokcumen, Keiran S. M. Smalley, Patrick J. Carroll, Richard D. Webster, Paganis Filippakopoulos, Stefan Knapp, Meenhard Herlyn, Eric Meggers, Chem. Eur. J. 2008, 14, 4816-4822.
abstract: In this comprehensive study we probe and verify the concept of designing unreactive bioactive metal complexes by investigating the consequences of replacing ruthenium in a bioactive half-sandwich kinase inhibitor scaffold by its heavier homolog osmium.
Solid Phase Synthesis of
Tris-Heteroleptic Ru(II) Complexes and Application to
Acetylcholinesterase Inhibition
Seann P. Mulcahy, Shan Li, Ricarda Korn, Xiulan Xie, Eric
Meggers, Inorg. Chem. 2008, 47,
5030-5032.
abstract: A synthetic route with two consecutive coordination chemistry
steps on solid support affords tris-heteroleptic ruthenium(II)
polypyridyl complexes in high purities and good yields. As an
application the identification of a nanomolar acetylcholinesterase
inhibitor from a small ruthenium complex library is reported.
Synthesis of
Cyclopentadienyl Ruthenium Complexes Bearing Pendant Chelating
Picolinates through an Electrophilic Precursor
Craig Streu, Patrick J. Carroll, Rakesh K. Kohli, Eric
Meggers, J. Organomet. Chem. 2008, 693,
551-556.
abstract: This note reports the facile synthesis of two ruthenium
cyclopentadienyl half-sandwich complexes functionalized with
coordinating alpha-picolinates. The synthetic approach involves the
(chloromethylcyclopentadienyl)(benzene)ruthenium(II) cation as a useful
common building block for cyclopentadienyl complexes bearing anchored
ligands.
2007
Duplex Formation of the
Simplified Nucleic Acid GNA
Mark K. Schlegel, Adam E. Peritz, Krisada Kittigowittana,
Lilu Zhang, Eric Meggers, ChemBioChem 2007,
8, 927-932.
abstract: Glycol nucleic acid (GNA) contains an acyclic backbone with
propylene glycol nucleosides that are connected by phosphodiester
bonds. The fullpaper characterizes the duplex formation properties of
this simplified nucleic acid.
download article · 700K PDF
Exploring Chemical
Space with Organometallics: Ruthenium Complexes as Protein Kinase
Inhibitors
Eric Meggers, G. Ekin Atilla-Gokcumen, Howard Bregman,
Jasna Maksimoska, Seann P. Mulcahy, Nicholas Pagano, and Douglas S.
Williams, Synlett 2007, 8,
1177-1189.
abstract: ACCOUNT ARTICLE: Complementing organic elements with a metal
center provides new opportunities for building three dimensional
structures with unique and defined shapes. Such access to unexplored
chemical space may lead to the discovery of molecules with
unprecedented properties. Along these lines, this account article
describes our successful design of highly potent and selective
ruthenium-based inhibitors for the protein kinases GSK-3 and Pim-1 by
using the class of indolocarbazole alkaloids as a lead structure.
download article · 700K PDF
Ruthenium Half-Sandwich
Complexes as Protein Kinase Inhibitors: Derivatization of the
Pyridocarbazole Pharmacophore Ligand
Nicholas Pagano, Jasna Maksimoska, Howard Bregman, Douglas
S. Williams, Richard D. Webster, Feng Xue and Eric Meggers, Org.
Biomol. Chem. 2007, 5, 1218-1227.
abstract: A general route to ruthenium pyridocarbazole
half-sandwich complexes was developed and applied to the synthesis of
sixteen new compounds, many of which display modulated protein kinase
inhibition properties.
download article ·
338K PDF
Platinum Complex as Nanomolar
Protein Kinase Inhibitor
Douglas S. Williams, Patrick J. Carroll, and Eric Meggers,
Inorganic Chemistry 2007, 46,
2944-2946.
abstract: A pyridocarbazole platinum complex, which matches the overall
shape of the natural product staurosporine, binds with high affinity at
the ATP binding site of glycogen synthase kinase 3.
download article · 159K
PDF
An Organometallic
Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces
Apoptosis in Human Melanoma Cells
Keiran S.M. Smalley, Rooha Contractor, Nikolas K. Haass,
Angela N. Kulp, G. Ekin Atilla-Gokcumen, Douglas S. Williams, Howard
Bregman, Keith T. Flaherty, Maria S. Soengas, Eric Meggers, and
Meenhard Herlyn, Cancer Research 2007, 67,
209-217.
abstract: We describe an organometallic glycogen synthase kinase 3ß
(GSK3ß) inhibitor (DW1/2) as a potent activator of p53 and inducer of
cell death in otherwise highly chemoresistant melanoma cells.
download article · 511K
PDF
2006
Synthesis and cyclometalation of a
pyrido[3,2-e]-2,10b-diaza-cyclopenta[c] fluorene-1,3-dione
scaffold
S. P. Mulcahy, P. J. Carroll, E. Meggers, Tetrahedron
Lett. 2006, 47, 8877-8880.
abstract: The synthesis of a
pyrido[3,2-e]-2,10b-diaza-cyclopenta[c]fluorene-1,3-dione scaffold is
disclosed, which was synthesized using a Suzuki cross-coupling reaction
and an intramolecular Heck cyclization as the key steps. This
heterocyclic system can serve as a bidentate ligand as demonstrated by
the formation and structural analysis of a derived ruthenium complex.
The new scaffold constitutes an interesting candidate for the
development of organometallic protein kinase inhibitors.
download article · 170K
PDF
Ruthenium Half-Sandwich Complexes as Protein
Kinase Inhibitors: An N-Succinimidyl Ester for Rapid Derivatizations of
the Cyclopentadienyl Moiety
H. Bregman and E. Meggers, Org. Lett. 2006,
8, 5465-5468.
abstract: Cyclopentadienyl half-sandwich ruthenium complexes have been
demonstrated to be promising scaffolds as protein kinase inhibitors. In
order to rapidly identify derivatives which display modified
pharmacological properties, we developed the synthesis of an
organoruthenium compound bearing an N-succinimidyl ester at the
cyclopentadienyl moiety. The quenching of this activated ester with a
library of primary amines, followed by testing of the resulting amide
library, led to the identification of inhibitors with improved
potencies and kinase selectivities.
download article · 217K
PDF
Ruthenium-Induced Allylcarbamate Cleavage in
Living Cells
C. Streu and Eric Meggers, Angw. Chem. Int. Ed.
2006, 5645-5648.
abstract: Towards the goal of designing catalytic organometallics as
tools for cellular chemical biology, a ruthenium catalyzed release of
amines from their respective allylcarbamates is disclosed which
tolerates the combination of water, air, and thiols, and it is
demonstrated that this reaction can be performed inside living
mammalian cells.
download
article · 642K PDF
Organometallic Compounds with Biological
Activity: A Very Selective and Highly Potent Cellular Inhibitor for
Glycogen Synthase Kinase 3
G. E. Atilla, D. S. Williams, H. Bregman, N. Pagano, E.
Meggers, ChemBioChem 2006, 1443-1450.
abstract: Like an organic molecule! A chemically inert ruthenium
complex acts as metallopharmaceutic inhibitor of the protein kinase
GSK-3 by targeting its ATP-binding site. It is shown to switch on the
Wnt signal transduction pathway inside living cells and in Xenopus
embryos, which developed a hyperdorsalized phenotype on administration
of the complex.
download article ·
602K PDF
Synthesis of Glycol Nucleic Acids
L. Zhang, A. E. Peritz, P. J. Carroll, E. Meggers,
SYNTHESIS 2006, 645-653.
abstract: Starting from glycidol, the synthesis of dimethoxytritylated
glycol nucleoside phosphor-amidites of adenine (A), thymine (T), uracil
(U), guanine (G), and cytosine (C) is reported. These phosphoramidites
are the building blocks for the automated solid phase synthesis of GNA
oligonucleotides and it is demonstrated that derived GNA duplexes with
completely acyclic backbones considerably exceed the thermal
stabilities of analogous DNA duplexes.
download article · 63K
PDF
Ruthenium Half-Sandwich Complexes Bound to
Protein Kinase Pim-1
J. É. Debreczeni, A. N. Bullock, G. E. Atilla, D. S.
Williams, H. Bregman, S. Knapp, E. Meggers, Angewandte Chemie Int.
Ed. 2006, 45, 1580-1585.
abstract: Like an organic molecule! A chemically inert ruthenium
complex acts as metallopharmaceutic inhibitor of the protein kinase
GSK-3 by targeting its ATP-binding site. It is shown to switch on the
Wnt signal transduction pathway inside living cells and in Xenopus
embryos, which developed a hyperdorsalized phenotype on administration
of the complex.
download
article · 902K PDF
Rapid Access to Unexplored Chemical Space by Ligand Scanning
Around a Ruthenium Center: Discovery of Potent and Selective Protein
Kinase Inhibitors
H. Bregman, P. J. Carroll, E. Meggers, J. Am. Chem.
Soc. 2006, Volume 128, 877-884.
abstract: An important objective for the discovery of compounds with
unique biological activities is the development of methods for the
synthesis of molecular scaffolds with defined three-dimensional shapes.
In this paper we present a strategy that allows a rapid scanning of
ligands around a ruthenium center in the search for ligand spheres that
are complementary in shape and functional group presentation to ATP
binding sites of protein kinases. Following this approach, we have
identified octahedral ruthenium complexes as potent inhibitors for the
protein kinases Pim1, MSK1, and GSK3a.
download article · 396K
PDF
2005
Switching on a Signaling Pathway with an Organoruthenium
Complex
D. S. Williams, G. E. Atilla, H. Bregman, A. Arzoumanian,
P. S. Klein, and E. Meggers, Angewandte Chemie Int. Ed. 2005,
Volume 117, 1984-1987.
abstract: Like an organic molecule! A chemically inert ruthenium
complex acts as metallopharmaceutic inhibitor of the protein kinase
GSK-3 by targeting its ATP-binding site. It is shown to switch on the
Wnt signal transduction pathway inside living cells and in Xenopus
embryos, which developed a hyperdorsalized phenotype on administration
of the complex.
download article ·
223K PDF
An
Extremely Stable and Orthogonal DNA Base Pair with a Simplified
Three-Carbon Backbone
L. Zhang and E. Meggers; J. Am. Chem. Soc. 2005,
Volume 127, 74-75.
abstract: A nucleotide C3HQ with a minimal three-carbon backbone
displays unprecedented pairing strength and orthogonality in a homopair
C3HQ:C3HQ in the presence of one equivalent of Cu2+. The
pairing stability in DNA even exceeds the related base pair having the
regular 2'-deoxyribose backbone. This discovery of a synergy between an
artificial backbone and base-pairing scheme opens new avenues for the
economical design of modified oligonucleotides with tailored
properties.
download article · 112K
PDF
Pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6
H)-diones: Synthesis, Cyclometalation, and Protein Kinase
Inhibition
H. Bregman, D. S. Williams, E. Meggers;
SYNTHESIS, 2005, 1521-1527.
abstract: Synthetic routes to
pyrido[2,3-a]pyrrolo[3,4-c]carba-zole-5,7(6H)-diones are disclosed and
examples for their subsequent transformations into cyclometalated
protein kinase inhibitors are presented.
download article ·
397K PDF
A Simple Glycol Nucleic Acid
L. Zhang, A. Peritz, E. Meggers; J. Am. Chem.
Soc. 2005, Volume 127, 4174-4175.
abstract: A glycol nucleic acid (GNA) with an acyclic propylene glycol
phosphodiester backbone forms stable antiparallel duplexes following
the Watson-Crick base pairing rules.
download article · 112K
PDF
2004
An
Organometallic Inhibitor for Glycogen Synthase Kinase 3
H. Bregman, D. S. Williams, G. E. Atilla, P. J. Carroll,
E. Meggers; J. Am. Chem. Soc. 2004, Volume 126,
13594-13595.
abstract: Replacing natural products with kinetically inert metal
complexes may lead to a new class of therapeutics in which a metal
center plays the role of an innocent bystander, organizing the
orientation of the organic ligands in the receptor space. As an example
of this approach, a ruthenium complex is described that copies the
binding mode of indolocarbazole protein kinase inhibitors and serves as
a reversible, low-nanomolar inhibitor for glycogen synthase kinase 3
(GSK-3).
download article · 112K
PDF
Ruthenium Complexes as Protein Kinase Inhibitors
L. Zhang, P. J. Carroll, E. Meggers; Organic
Letters 2004, Volume 6, 521-523.
abstract: Replacing complex natural products with simple metal
complexes could lead to a new class of metallopharmaceuticals in which
the metal center plays mainly a structural role. A strategy is
introduced for the creation of Ru complex-based protein kinase
inhibitors, morphed out of the class of indolocarbazole inhibitors with
the alkaloid staurosporine as its most prominent member.
download article · 78K
PDF
Selected Earlier Publications
Structure of a
Copper-Mediated Base Pair in DNA
S. Atwell, E. Meggers, G. Spraggon, P. G. Schultz; J.
Am. Chem. Soc. 2001, Volume 123, 12364-12367.
abstract: This paper reports the first crystal structure of a
metallo-base pair within a DNA duplex.
A Novel Copper-Mediated DNA
Base Pair
E. Meggers, P. L. Holland, W. B. Tolman, F. E. Romesberg,
P. G. Schultz; J. Am. Chem. Soc. 2000, Volume 122,
10714-10715.
abstract: This publication is the first report of a designed
metallo-base pair in a DNA duplex. The results demonstrate that
interbase metal coordination can replace the hydrogen bonding schemes
found in the natural base Watson-Crick base pairs.
Sequence Dependent Hole
Transfer in DNA
E. Meggers, M. E. Michel-Beyerle, B. Giese; J. Am.
Chem. Soc. 1998, Volume 120, 12950-12955.
abstract: A guanine radical cation was site-selectively generated in
double stranded DNA and the charge transfer in different
oligonucleotide sequences was investigated. It was discovered, that the
overall charge transport in a mixed strand is a multistep hopping
process between G bases where the individual steps contribute to the
overall rate. The distance dependence is no longer described by the
beta-value of the superexchange mechanism.

